{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:43:34Z","timestamp":1793213014260,"version":"4.5.0"},"reference-count":70,"publisher":"American Society for Microbiology","issue":"8","license":[{"start":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T00:00:00Z","timestamp":1723593600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T00:00:00Z","timestamp":1723593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Clin Microbiol"],"published-print":{"date-parts":[[2024,8,14]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:sec>\n            <jats:title\/>\n            <jats:p>The laboratory diagnosis of antiviral resistance is a quickly changing field due to new drug availability, the sunsetting of older drugs, the development of novel technologies, rapid viral evolution, and the financial\/logistic pressures of the clinical laboratory. This mini-review summarizes the current state of clinically available antiviral resistance testing in the United States in 2024, covering the most commonly used test methods, mechanisms, and clinical indications for herpes simplex virus, cytomegalovirus, human immunodeficiency virus, influenza, hepatitis B virus, and hepatitis C virus drug resistance testing. Common themes include the move away from phenotypic to genotypic methods for first-line clinical testing, as well as uncertainty surrounding the clinical meaningfulness of minority variant detection as next-generation sequencing methods have become more commonplace.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1128\/jcm.00728-23","type":"journal-article","created":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T13:01:01Z","timestamp":1721912461000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":16,"title":["Practical updates in clinical antiviral resistance testing"],"prefix":"10.1128","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3712-9188","authenticated-orcid":true,"given":"Hannah","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Laboratory Medicine, Cleveland Clinic, Cleveland, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00102-15"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1128\/9781555819156.ch16"},{"key":"e_1_3_2_4_2","first-page":"1985","volume-title":"Manual of clinical microbiology","author":"Huang DD","year":"2019","unstructured":"Huang DD, Pinsky BA, Bankowski MJ. 2019. Susceptibility test methods: viruses, p 1985\u20132004. In Carroll KC, Pfaller MA, Landry ML, McAdam AJ, Patel R, Richter SS, Warnock DW (ed), Manual of clinical microbiology, 12th ed, Vol 2. ASM Press, Washington DC.","edition":"12"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.idc.2010.01.001"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2014.08.015"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.28.2.207"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.40.4.1017"},{"key":"e_1_3_2_9_2","unstructured":"World Health Organization. Laboratory methodologies for testing the antiviral susceptibility of influenza viruses: neuraminidase inhibitor (NAI). Available from: https:\/\/www.who.int\/teams\/global-influenza-programme\/laboratory-network\/quality-assurance\/antiviral-susceptibility-influenza\/neuraminidase-inhibitor. Retrieved 07 Jul 2024."},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1177\/00333549131280S212"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiz244"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01443-18"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.coviro.2014.06.003"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/s1386-6532(02)00263-9"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkv285"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2020.104711"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/tid.12241"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiad293"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiz577"},{"key":"e_1_3_2_20_2","unstructured":"Stanford University. HIV drug resistance database. Available from: https:\/\/hivdb.stanford.edu\/. Retrieved 27 Mar 2024."},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid2707.204593"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.12732"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21698"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gks1022"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2016.04.003"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.09.001"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.38.6.1246"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.42.1.242-249.2004"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1086\/590668"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000002191"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-06-688432"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy696"},{"key":"e_1_3_2_33_2","unstructured":"Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in adults and adolescents with HIV. Department of Health and Human Services. Available from: https:\/\/clinicalinfo.hiv.gov\/en\/guidelines\/adult-and-adolescent-arv. Retrieved 27 Mar 2024."},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.22246"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy874"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29800"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciad319"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiaa020"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2017.10.002"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.00829-23"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.00429-23"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.03214-14"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jit654"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiz298"},{"key":"e_1_3_2_45_2","first-page":"1962","volume-title":"Manual of clinical microbiology","author":"Shafer RW","year":"2019","unstructured":"Shafer RW, Boivin G, Chou S. 2019. Mechanisms of resistance to antiviral agents, p 1962\u20131984. In Carroll KC, Pfaller MA, Landry ML, McAdam AJ, Patel R, Richter SS, Warnock DW (ed), Manual of clinical microbiology, 12th ed, Vol. 2. ASM Press, Washington DC.","edition":"12"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciab583"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkad109"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofy294"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkg100"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23052727"},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00105-18"},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2020.104376"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmoldx.2019.06.003"},{"key":"e_1_3_2_54_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dky003"},{"key":"e_1_3_2_55_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.00253-22"},{"key":"e_1_3_2_56_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jix430"},{"key":"e_1_3_2_57_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.375"},{"key":"e_1_3_2_58_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofad146"},{"key":"e_1_3_2_59_2","doi-asserted-by":"publisher","DOI":"10.1128\/cmr.00052-22"},{"key":"e_1_3_2_60_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000001362"},{"key":"e_1_3_2_61_2","doi-asserted-by":"publisher","DOI":"10.1111\/irv.13079"},{"key":"e_1_3_2_62_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofz493"},{"key":"e_1_3_2_63_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2010.09.012"},{"key":"e_1_3_2_64_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-018-2459-9"},{"key":"e_1_3_2_65_2","unstructured":"Food and Drug Adminsitration Department of Health and Human Services. 2023. Proposed rule: medical devices; laboratory developed tests. Docket No. FDA-2023-N-2177 88 FR 68006. Federal register. Available from: https:\/\/www.federalregister.gov\/documents\/2023\/10\/03\/2023-21662\/medical-devices-laboratory-developed-tests"},{"key":"e_1_3_2_66_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-022-00809-7"},{"key":"e_1_3_2_67_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid2912.231146"},{"key":"e_1_3_2_68_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1913556"},{"key":"e_1_3_2_69_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2011.04.005"},{"key":"e_1_3_2_70_2","doi-asserted-by":"publisher","DOI":"10.3390\/v12050560"},{"key":"e_1_3_2_71_2","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens11070724"}],"container-title":["Journal of Clinical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/jcm.00728-23","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/jcm.00728-23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T13:02:07Z","timestamp":1723640527000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/jcm.00728-23"}},"subtitle":[],"editor":[{"given":"Romney M.","family":"Humphries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2024,8,14]]},"references-count":70,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8,14]]}},"alternative-id":["10.1128\/jcm.00728-23"],"URL":"https:\/\/doi.org\/10.1128\/jcm.00728-23","relation":{},"ISSN":["0095-1137","1098-660X"],"issn-type":[{"value":"0095-1137","type":"print"},{"value":"1098-660X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,14]]},"assertion":[{"value":"2024-07-25","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e00728-23"}}